GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Thymic epithelial tumors (TET) are rare neoplasms.
• Wingless and INT (WNT), NOTCH, and sonic hedgehog pathways are crucial for thymus and T-cell development.
• Understanding pathway activity in TET is important for T-cell development research.

Purpose of the Study:

• To analyze thymoma tissue microarrays for glioma associated oncogene homolog 1 (GLI1), NOTCH1, and catenin (cadherin-associated protein, beta 1) (CTNNB1) expression.
• To use these markers as surrogates for sonic hedgehog, NOTCH, and WNT pathway activity in thymic epithelial tumors.
• To investigate potential pathway dysregulation in thymoma.

Main Methods:

• A tissue microarray of 68 TET and eight benign thymus samples was analyzed.
• Fluorescent immunohistochemistry (AQUA) was used to assay GLI1, NOTCH1, and CTNNB1 expression.
• Expression levels were quantified to assess pathway activity.

Main Results:

• No significant differences in GLI1, CTNNB1, or NOTCH1 expression were observed between thymic tumors and benign thymus tissue.
• Mean GLI1 expression was 201 in tumors vs. 211 in benign thymus (p=0.31).
• Mean CTNNB1 expression was 222 in tumors vs. 306 in benign thymus (p=0.66).
• Mean NOTCH1 expression was 317 in tumors vs. 325 in benign thymus (p=0.82).

Conclusions:

• There is no evidence of preferential expression of GLI1, NOTCH1, or CTNNB1 in thymic epithelial tumors compared to benign thymus.
• High-throughput immunofluorescence with AQUA technology can effectively analyze protein expression in thymic tumors.
• This method helps overcome challenges posed by small sample sizes and tissue heterogeneity in rare tumor studies.